Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q3V016

Entry ID Method Resolution Chain Position Source
AF-Q3V016-F1 Predicted AlphaFoldDB

34 variants for Q3V016

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388865803 14 I>M No EVA
rs3388884762 32 S>R No EVA
rs3388865841 57 K>R No EVA
rs3388892299 94 Q>P No EVA
rs3388874997 105 F>I No EVA
rs3388884025 106 A>V No EVA
rs3388893853 129 E>Q No EVA
rs3388872397 147 Q>* No EVA
rs3397749971 155 K>R No EVA
rs3388865845 175 Y>* No EVA
rs3388884796 175 Y>F No EVA
rs3388893845 193 C>Y No EVA
rs3388883984 222 D>N No EVA
rs3388887449 238 L>W No EVA
rs3397762503 240 H>Y No EVA
rs3388872387 242 A>T No EVA
rs3388875054 249 F>I No EVA
rs3388893883 258 T>I No EVA
rs248677002 270 L>I No EVA
rs3388884044 315 A>T No EVA
rs3388884770 324 I>M No EVA
rs3388851377 355 A>T No EVA
rs3388893833 451 V>I No EVA
rs234697230 480 G>S No EVA
rs238942938 483 L>V No EVA
rs3388880933 486 R>L No EVA
rs3388872389 494 A>V No EVA
rs3388851284 513 P>S No EVA
rs1131814675 518 P>S No EVA
rs3397296915 548 G>V No EVA
rs3388892752 549 I>F No EVA
rs3388884054 562 E>D No EVA
rs3388874989 587 S>T No EVA
rs3388895109 587 S>Y No EVA

No associated diseases with Q3V016

16 regional properties for Q3V016

Type Name Position InterPro Accession
repeat Leucine-rich repeat 121 - 140 IPR001611-1
repeat Leucine-rich repeat 146 - 162 IPR001611-2
repeat Leucine-rich repeat 229 - 250 IPR001611-3
repeat Leucine-rich repeat 300 - 322 IPR001611-4
repeat Leucine-rich repeat 324 - 346 IPR001611-5
repeat Leucine-rich repeat 500 - 521 IPR001611-6
repeat Leucine-rich repeat 591 - 657 IPR001611-7
repeat Leucine-rich repeat, typical subtype 119 - 143 IPR003591-1
repeat Leucine-rich repeat, typical subtype 144 - 169 IPR003591-2
repeat Leucine-rich repeat, typical subtype 298 - 322 IPR003591-3
repeat Leucine-rich repeat, typical subtype 419 - 444 IPR003591-4
repeat Leucine-rich repeat, typical subtype 498 - 521 IPR003591-5
repeat Leucine-rich repeat, typical subtype 522 - 546 IPR003591-6
repeat Leucine-rich repeat, typical subtype 608 - 631 IPR003591-7
repeat Leucine-rich repeat, typical subtype 632 - 657 IPR003591-8
domain Leucine-rich repeat-containing N-terminal, plant-type 54 - 91 IPR013210

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

6 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
histone kinase activity Catalysis of the transfer of a phosphate group to a histone.
protein kinase activity Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.
protein serine/threonine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
protein tyrosine kinase activity Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.

6 GO annotations of biological process

Name Definition
histone modification The covalent alteration of one or more amino acid residues within a histone protein.
peptidyl-serine phosphorylation The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
peptidyl-threonine phosphorylation The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
protein autophosphorylation The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
protein phosphorylation The process of introducing a phosphate group on to a protein.
regulation of signal transduction by p53 class mediator Any process that modulates the frequency, rate or extent of signal transduction by p53 class mediator.

10 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q92630 DYRK2 Dual specificity tyrosine-phosphorylation-regulated kinase 2 Homo sapiens (Human) PR
Q13627 DYRK1A Dual specificity tyrosine-phosphorylation-regulated kinase 1A Homo sapiens (Human) PR
Q9NR20 DYRK4 Dual specificity tyrosine-phosphorylation-regulated kinase 4 Homo sapiens (Human) PR
Q9H2X6 HIPK2 Homeodomain-interacting protein kinase 2 Homo sapiens (Human) EV
Q9H422 HIPK3 Homeodomain-interacting protein kinase 3 Homo sapiens (Human) SS
Q8NE63 HIPK4 Homeodomain-interacting protein kinase 4 Homo sapiens (Human) PR
Q61214 Dyrk1a Dual specificity tyrosine-phosphorylation-regulated kinase 1A Mus musculus (Mouse) PR
Q9QZR5 Hipk2 Homeodomain-interacting protein kinase 2 Mus musculus (Mouse) SS
Q8BI55 Dyrk4 Dual specificity tyrosine-phosphorylation-regulated kinase 4 Mus musculus (Mouse) PR
Q4V793 Hipk4 Homeodomain-interacting protein kinase 4 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MATIQSETDC YDIIEVLGKG TFGEVAKGWR RSTGEMVAIK ILKNDAYRSR IIKNELKLLR
70 80 90 100 110 120
CVRGLDPDEA HVIRFLEFFH DALKFYLVFE LLEQNLFEFQ KENNFAPLPA RHIRTVTLQV
130 140 150 160 170 180
LRALARLKEL AIIHADLKPE NIMLVDQTRC PFRVKVIDFG SASIFSEVRY VKEPYIQSRF
190 200 210 220 230 240
YRAPEILLGL PFCEKVDVWS LGCVMAELHL GWPLYPGNNE YDQVRYICET QGLPKPHLLH
250 260 270 280 290 300
AARKAHHFFK RNPHPDATNP WQLKSSADYL AETKVRPLER RKYMLKSLDQ IETVNGGGAV
310 320 330 340 350 360
SRLSFPDREA LAEHADLKSM VELIKRMLTW ESHERISPSA ALRHPFVSMQ QLRSAHEATR
370 380 390 400 410 420
YYQLSLRGCR LSLQVDGKPP PPVIASAEDG PPYYRLAEEE ETAGLGGVTG SGSFFREDKA
430 440 450 460 470 480
PGMQRAIDQL DDLSLQEARR GLWSDTRADM VSDMLVPLKV ASTSHRVPDS GPEPILAFYG
490 500 510 520 530 540
SRLTGRHKAR KAPAGSKSDS NFSNLIRLSQ ASPEDAGPCR GSGWEEGEGR TTSTEPSVIP
550 560 570 580 590 600
QREGDGPGIK DRPMDAERPG PELFDPSSCP GEWLSEPEWT LEGIRGSRAQ GLPAHHPHPH
610
GPPRTTSFLQ HVGGHH